Sotac Pharmaceuticals (SOTAC.NS) Stock Price
Sotac Pharmaceuticals Price
Over the last 5 years Sotac Pharmaceuticals grew revenue by 27.7% annually, reaching 969.87 M INR. Earnings per share have grown at 146.9% per year over the last 5 years. For Sotac Pharmaceuticals, the net margin of 8.3% is up versus -4.8% a few years ago. At today's price the dividend yield works out to roughly 0.11%. The payout ratio is around 1% of earnings.
Sotac Pharmaceuticals stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Sotac Pharmaceuticals business model & stock analysis
Frequently asked questions about Sotac Pharmaceuticals
Converted at the current exchange rate, the Sotac Pharmaceuticals share trades at 0.84 EUR (90.05 INR).
The revenue cannot currently be calculated for Sotac Pharmaceuticals.
The profit cannot currently be calculated for Sotac Pharmaceuticals.
The P/E ratio cannot be calculated for Sotac Pharmaceuticals at the moment.
The P/S cannot be calculated for Sotac Pharmaceuticals currently.
The Eulerpool Quality Score for Sotac Pharmaceuticals is 2/10.
The ISIN of Sotac Pharmaceuticals is INE0O2D01012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sotac Pharmaceuticals is SOTAC.NS. The ticker symbol is used to trade Sotac Pharmaceuticals shares on the stock exchange.
Sotac Pharmaceuticals stock
Sotac Pharmaceuticals Peer Group
Sotac Pharmaceuticals FIGI
All fundamentals and in-depth analysis of Sotac Pharmaceuticals
Our stock analysis for Sotac Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sotac Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.